antibiotics

1. MacrolidesMacrolides

2. 1.1. ErythromycinErythromycin
2.2. AzithromycinAzithromycin
3.3. ClarithromycinClarithromycin
4.4. ClindamycinClindamycin
5.5. AmikacinAmikacin
6.6. VancomycinVancomycin
7.7. LinezolidLinezolid
8.8. StreptograminsStreptogramins

5. 1 – 2 weeks1 – 2 weeks

8. AzithromycinAzithromycin

9. Children – 10 mg /Kg /day—3daysChildren – 10 mg /Kg /day—3days

10. ClarithromycinClarithromycin
1.1. H-pylori regimH-pylori regim
2.2. MACMAC
 second linesecond line
1.1. LeprosyLeprosy
2.2. Atypical mycobacterial diseaseAtypical mycobacterial disease

14. Vancomycin useVancomycin use
1.1. Psuedo membranous colitis - oralPsuedo membranous colitis - oral
2.2. IV – serious MRSA infectionsIV – serious MRSA infections
3.3. Enterococcal EndocarditisEnterococcal Endocarditis
4.4. Bacterial meningitis - + iv ceftriaxone /Bacterial meningitis - + iv ceftriaxone /
cefotaximecefotaxime
5.5. Dialysis patientsDialysis patients
6.6. Cancer chemotherapyCancer chemotherapy
7.7. Penicillin resistant pneumococcal infectionPenicillin resistant pneumococcal infection
8.8. Diphtheroid infectioonDiphtheroid infectioon
9.9. Surgical px. In MRSA prevalant areasSurgical px. In MRSA prevalant areas

15. LinezolidLinezolid
 VRSAVRSA
 VREVRE
1.1. Serious hospital acquire pneumoniasSerious hospital acquire pneumonias
2.2. Febrile neutropeniaFebrile neutropenia
3.3. Wound infections by VRE , VRSA ,MDRWound infections by VRE , VRSA ,MDR
streptococcus pneumoniastreptococcus pneumonia
4.4. Not suitable for enterococcal endocarditisNot suitable for enterococcal endocarditis
 Very few side effectsVery few side effects
 MAO inhibiterMAO inhibiter

16. Urinary AntisepticsUrinary Antiseptics
1.1. NitrofurantoinNitrofurantoin
2.2. MethanamineMethanamine
3.3. Naldixic acidNaldixic acid